Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics disclosed the grant of inducement stock options totaling 135,470 shares to twelve new non-executive employees as part of its Amended and Restated 2021 Inducement Plan. The options have an exercise price of $3.80, vest over three years, and align with Nasdaq listing requirements. The company focuses on developing innovative t…